Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-08

Clinical Trial Update: Testing Insect Repellents Against Musca Sorbens, the Vector of Trachoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating insect repellents against Musca sorbens, a vector of Trachoma, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Trachoma | Phase 2 | Status: COMPLETED